IMCD stock sits 21.82 percent below Goldman Sachs target

Published on 10/16/2026 at 10:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman Sachs set a EUR 133.00 target on October 2, 2026. IMCD stock costs EUR 103.98 on October 16, 2026, 21.82 percent below it.

Analyst target and reporting date

Goldman Sachs set a EUR 133.00 target on October 2, 2026.
IMCD reported first-half EBITA of EUR 285 million, up 8 percent in 2026.
IMCD stock trades at EUR 103.98 at 10:44 a.m. CEST at Lang & Schwarz on October 16, 2026, 0.61 percent above the Xetra close of October 15, 2026.
IMCD will publish first nine months 2026 results on November 5, 2026.

Moderner gläserner Bürokomplex am Hafen mit Wasserbecken und Terrasse, architektonische Visualisierung — Architektur-Render eines modernen Bürogebäudes visualisiert Hauptsitz-Stil von IMCD N.V., ISIN NL0010801007, an Wasserfront, Illustration mit AI erstellt.

IMCD (ISIN NL0010801007) stock was trading at EUR 103.98 at Lang & Schwarz on October 16, 2026, at 10:44 a.m. CEST, 0.61 percent above the Xetra close of October 15, 2026 at EUR 103.35. Goldman Sachs set a EUR 133.00 target for the stock on October 2, 2026, putting the target 27.92 percent above the current price, according to Investire.biz.

Three reporting milestones shape the picture

IMCD reported operating EBITA of EUR 130 million for the first three months of 2026, according to 6ix on July 29, 2026. The company then reported first-half EBITA of EUR 285 million, up 8 percent on a constant-currency basis, while free cash flow reached EUR 222 million.

The latest dated company event was a results webcast invitation published on October 15, 2026. Globenewswire reported that IMCD will publish its first nine months 2026 results on November 5, 2026, at 7:00 a.m. CET.

What does the EUR 133.00 target imply?

The Goldman Sachs target implies 27.92 percent upside from the Lang & Schwarz price, using the target and the EUR 103.98 quote in the same currency. The gap gives the upcoming results a clear test: IMCD must show that first-half growth can continue into the third quarter without sacrificing profitability.

Dates investors can put on the calendar

IMCD's first nine months 2026 results are scheduled for November 5, 2026, followed by the full-year 2026 results on February 19, 2027. The company lists both dates in its financial calendar on its IMCD investor-relations page.

IMCD stock keeps the next test ahead

IMCD's first-half figures combine 8 percent constant-currency EBITA growth with EUR 222 million of free cash flow, while the share price remains below the Goldman Sachs target. The next scheduled report will show whether the second-half setup is translating into fresh operating growth.

The further course of trading is shown by the continuously updated real-time quote of IMCD stock.